Valuation: Sera Prognostics, Inc.

Market Cap 78.74M 71.21M 65.73M 59.5M 112M 7.4B 116M 789M 314M 3.96B 296M 289M 12.6B P/E 2026 *
-3x
P/E 2027 * -3.47x
Enterprise Value 78.74M 71.21M 65.73M 59.5M 112M 7.4B 116M 789M 314M 3.96B 296M 289M 12.6B EV / Sales 2026 *
394x
EV / Sales 2027 * 38.1x
Free-Float
85.85%
Yield 2026 *
-
Yield 2027 * -
1 day+2.06%
1 week-4.81%
Current month-2.94%
1 month-4.35%
3 months-1.98%
6 months+17.16%
Current year-32.88%
1 week 1.91
Extreme 1.91
2.22
1 month 1.91
Extreme 1.91
2.22
Current year 1.56
Extreme 1.56
3.85
1 year 1.56
Extreme 1.56
3.85
3 years 1.37
Extreme 1.37
12.36
5 years 1.1
Extreme 1.1
12.36
10 years 1.1
Extreme 1.1
15.5
Manager TitleAgeSince
Chief Executive Officer 52 2023-05-31
Director of Finance/CFO 47 2026-08-30
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 74 2011-04-19
Chairman 58 2023-06-07
Director/Board Member 59 2011-10-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/12/26 Sell

Chief Technology Officer

-8,024 0.0209%
9/10/26 Sell

Chief Executive Officer

-7,022 0.0182%
9/10/26 Sell

General Counsel

-2,190 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+2.06%-4.81%-36.54%+17.16% 78.74M
-1.23%-0.54%+24.03%+71.38% 793B
+0.11%+0.49%+22.80%+70.59% 90.34B
-1.01%+9.14%+32.35%+149.52% 70.53B
-4.04%-2.12%+25.07%+59.73% 49.73B
-1.98%-1.12%-13.24%+6.45% 48.43B
-16.84%+6.87%+36.33%+579.20% 35.26B
-2.15%+7.09%+25.70%+34.58% 33.41B
-3.76%-1.98%-4.47%-49.39% 32.72B
-1.29%+2.02%+59.04%+97.23% 29.17B
Average -3.01%+1.12%+17.11%+103.64% 118B
Weighted average by Cap. -1.83%+0.38%+23.43%+84.23%

Financials

2026 *2027 *
Net sales 200K 181K 167K 151K 285K 18.8M 294K 2M 796K 10.05M 751K 735K 31.99M 2.07M 1.87M 1.73M 1.56M 2.95M 194M 3.03M 20.71M 8.23M 104M 7.76M 7.59M 331M
Net income -34.45M -31.15M -28.76M -26.03M -49.12M -3.24B -50.59M -345M -137M -1.73B -129M -127M -5.51B -30.95M -27.99M -25.83M -23.38M -44.13M -2.91B -45.45M -310M -123M -1.56B -116M -114M -4.95B
Net Debt - -
Projected Income Statement - Annual - Sera Prognostics, Inc.
Logo Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Employees
72
Date Price Change Volume
26-11-12 US$1.980 +2.06% 18,801
26-11-11 US$1.940 -2.51% 84,546
26-11-10 US$1.990 -9.13% 54,284
26-11-09 US$2.190 0.00% 30,378
26-11-06 US$2.190 +5.29% 219,003
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sera Prognostics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.980USD
Average target price
5.000USD
Spread / Average Target
+152.53%
  1. Stock Market
  2. Stocks
  3. SERA Stock